Identification of covalent attachment site of antiestrogenic estradiol 11β-derivatives on human estrogen receptor α ligand-binding domain

被引:3
|
作者
Aliau, S
Mattras, H
Borgna, JL
机构
[1] INSERM U540, F-34090 Montpellier, France
[2] INSERM U554, F-34090 Montpellier, France
关键词
estrogen receptor; ligand-binding domain; estradiol; 11; beta-derivatives; affinity labeling; mass spectrometry;
D O I
10.1016/j.jsbmb.2005.09.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Affinity labeling of human estrogen receptor alpha (ER alpha) by high affinity and antiestrogenic estradiol (E-2) 11 beta-derivatives, 11 beta-bromoacetamidoethoxyphenylE(2) (11BAEOPE(2)) and 11 beta-bromoacetamidopentoxyphenylE(2) (11BAPOPE(2)) was studied using glutathione-S-transferase (GST) fused to the ligand-binding domain (LBD) of human ER alpha. To identify and quantify the electrophile covalent attachment sites on LBD, [C-14]11BAEOPE(2)- and [C-14]11BAPOPE(2)-alkylated LBD were separated from GST, purified, and then trypsinized. HPLC of LBD tryptic fragments afforded one and two radioactive peaks (the ratio of the two latter peaks was 84/16) in the chromatograms related to LBD alkylated by 11BAEOPE(2) and 11BAPOPE(2), respectively. Mass spectrometry (MS) analyses of the fractions related to the single peak and to the major one of the two peaks showed signals which accurately matched the mass of electrophile-alkylated Cys(530)Lys(531) LBD tryptic peptide, whereas no signal compatible with an alkylated form of an LBD tryptic peptide was detected in the MS analysis of the minor peak-related fractions. MS/MS analysis of alkylated CysLys dipeptide revealed the presence of fragments that unambiguously designated the Cys S as the covalent attachment site of the electrophiles. We attempted to interpret the biochemical data by molecular modeling using various crystallographic structures of human LBD-ligand complexes. In agreement with the endocrine proper-ties of electrophiles, labeling at Cys(530) could be accounted for by a LBD structure derived from LBD bound to 4-hydroxytamoxifen, a triphenylethylene antiestrogen. The common attachment to Cys(530) of estrogenic E-2 17 alpha-derivatives [H. Mattras, S. Aliau, E. Demey, J. Poncet, J.L. Borgna, Mass spectrometry identification of covalent attachment sites of two related estrogenic ligands on human estrogen receptor alpha, J. Steroid Biochem. Mol. Biol. 98 (4-5), in press] and antiestrogenic E-2 11 beta-derivatives suggests that the LBD portion encompassing this amino acid possesses a marked plasticity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:111 / 121
页数:11
相关论文
共 28 条
  • [1] Mass spectrometry identification of covalent attachment sites of two related estrogenic ligands on human estrogen receptor α
    Mattras, H
    Aliau, S
    Demey, E
    Poncet, JL
    Borgna, JL
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 98 (4-5) : 236 - 247
  • [2] Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
    Gonzalez, Thomas L.
    Hancock, Molly
    Sun, Siqi
    Gersch, Christina L.
    Larios, Jose M.
    David, Waddie
    Hu, Jiantao
    Hayes, Daniel F.
    Wang, Shaomeng
    Rae, James M.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 611 - 622
  • [3] Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
    Thomas L. Gonzalez
    Molly Hancock
    Siqi Sun
    Christina L. Gersch
    Jose M. Larios
    Wadie David
    Jiantao Hu
    Daniel F. Hayes
    Shaomeng Wang
    James M. Rae
    Breast Cancer Research and Treatment, 2020, 180 : 611 - 622
  • [4] Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid
    Hegy, GB
    Shackleton, CHL
    Carlquist, M
    Bonn, T
    Engstrom, O
    Sjoholm, P
    Witkowska, HE
    STEROIDS, 1996, 61 (06) : 367 - 373
  • [5] Utilizing the Estrogen Receptor Ligand-Binding Domain for Controlled Protein Translocation to the Insoluble Fraction
    Davis, James R.
    Mossalam, Mohanad
    Lim, Carol S.
    PHARMACEUTICAL RESEARCH, 2012, 29 (12) : 3455 - 3463
  • [6] Utilizing the Estrogen Receptor Ligand-Binding Domain for Controlled Protein Translocation to the Insoluble Fraction
    James R. Davis
    Mohanad Mossalam
    Carol S. Lim
    Pharmaceutical Research, 2012, 29 : 3455 - 3463
  • [7] The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
    Anstead, GM
    Carlson, KE
    Katzenellenbogen, JA
    STEROIDS, 1997, 62 (03) : 268 - 303
  • [8] Sensitive detection of estradiol based on ligand binding domain of estrogen receptor and gold nanoparticles
    Busayapongchai, Pimchanok
    Siri, Sineenat
    ANALYTICAL BIOCHEMISTRY, 2017, 518 : 60 - 68
  • [9] Homology modelling of the ligand-binding domain of glucocorticoid receptor: binding site interactions with cortisol and corticosterone
    Dey, R
    Roychowdhury, P
    Mukherjee, C
    PROTEIN ENGINEERING, 2001, 14 (08): : 565 - 571
  • [10] Intact noncovalent dimer of estrogen receptor ligand-binding domain can be detected by electrospray ionization mass spectrometry
    Witkowska, HE
    Green, BN
    Carlquist, M
    Shackleton, CHL
    STEROIDS, 1996, 61 (07) : 433 - 438